Immunocore Holdings (IMCR) Change in Receivables (2021 - 2026)
Immunocore Holdings (IMCR) posted Change in Receivables of $7.9 million for Q1 2026, up 497.69% sequentially from -$2.0 million in Q4 2025, and up 1048.56% YoY from $690427.0 in Q1 2025.
Immunocore Holdings (IMCR) Change in Receivables (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported Change in Receivables for 6 years, with the latest figure at $7.9 million in Q1 2026.
- Quarterly Change in Receivables rose 1048.56% year-over-year to $7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 million (up 203.01% YoY) and the FY2025 annual result came in at $7.3 million, down 40.59% from the prior year.
- Change in Receivables grew to $7.9 million in Q1 2026 per IMCR's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $10.2 million in Q4 2023 and troughed at -$8.3 million in Q4 2022.
- A 5-year average of $2.1 million and a median of $2.7 million in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables slumped 253.98% in 2025, then surged 1048.56% in 2026.
- Over 5 years, Change in Receivables stood at -$8.3 million in 2022, then jumped by 223.31% to $10.2 million in 2023, then plunged by 87.33% to $1.3 million in 2024, then plunged by 253.98% to -$2.0 million in 2025, then jumped by 497.69% to $7.9 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $7.9 million, -$2.0 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn | 14.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.62 Mn |
| Jun 30, 2026 | 14.62 Mn |
| Mar 31, 2026 | 7.93 Mn |
| Mar 31, 2026 | 7.93 Mn |
| Dec 31, 2025 | -1.99 Mn |
| Dec 31, 2025 | -1.99 Mn |
| Sep 30, 2025 | 5.99 Mn |
| Sep 30, 2025 | 5.99 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | -836,000.00 |
| Mar 31, 2025 | -836,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 6.20 Mn |
| Mar 31, 2024 | 6.20 Mn |